Log In
Print
BCIQ
Print
Print this Print this
 

DC-AdGM-CAIX

  Manage Alerts
Collapse Summary General Information
Company Kite Pharma Inc.
DescriptionFusion molecule combined of carbonic anhydrase IX (CAIX) and granulocyte monocyte colony stimulating factor (GM-CSF)
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationRenal cancer
Indication DetailsTreat clear cell renal cell carcinoma (RCC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today